Comparative evaluation of Sensititre® YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts

Mycoses

Volumn 47, Issue 9-10, 2004, Pages 397-401

  Lombardi, Gianluigi ^a,b   Farina, C ^a,c   Andreoni, S ^a,d   Fazii, P ^a,e   Faggi, E ^a,f   Pini, G ^f   Manso, E ^a,g   Nanetti, A ^h   Mazzoni, A ^a,h  

^a AMCLI   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^e SPIRITO SANTO HOSPITAL   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g Ospedale Regionale Torrette   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

E test; NCCLS M27A; Sensititre YeastOne; Susceptibility testing; Yeasts

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DILUTION; DRUG SENSITIVITY; FUNGUS ISOLATION; INTERMETHOD COMPARISON; LABORATORY TEST; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; COLORIMETRY; ITRACONAZOLE; KETOCONAZOLE; LABORATORIES; MICROBIAL SENSITIVITY TESTS; QUALITY ASSURANCE, HEALTH CARE; REFERENCE STANDARDS;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; FUNGI;

EID: 7944235687     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2004.01013.x     Document Type: Article

References (9)

1. Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis 1996; 22: S112-8.
2. Pfaller MA, Jones RN, Messer SA, Edimond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida/other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 1998; 30: 121-9.
3. Graybill JR, Montalbo E, Kirkpatrick WR, Luther MF, Revankar SG, Patterson TF. Fluconazole versus Candida albicans: a complex relationship. Antimicrob Agents Chemother 1998; 42: 2938-42.
4. Espinell-Ingroff A, Pfaller MA. Antifungal agents and susceptibility testing. In: Murray PR, Baron J, Pfaller MA, Tenover FC, Yolken RH (eds), Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology, 1995: 1405-14.
5. Fromtling RA, Galgiani JN, Pfaller MA et al. Multicenter evaluation of a broth/macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother 1993; 37: 39-45.
6. Galgiani JN, Reiser J, Brass C, Espinel-Ingroff A, Gordon MA, Kerkering TM. Comparison of the relative susceptibility of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob Agents Chemother 1987; 31: 1343-7.
7. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standards. Document M27A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
8. Rex JH, Pfaller MA, Galgiani JN et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 25: 235-47.
9. Riesselman MH, Hazen KC, Cutler JE. Determination of antifungal MICs by a rapid susceptibility assay. J Clin Microbiol 2000; 38: 333-40.